Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Olympus (7733 JT)
Watchlist
21
Analysis
Health Care
•
Japan
OLYMPUS CORPORATION manufactures optoelectronic products. The Company's products include cameras, video sets, endoscopes for medicine and industrial use, microscopes, analytical equipment, office communication systems, and laseroptical scanners.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Olympus Corp
•
15 May 2019 08:19
Olympus: FY03/19 Affected by One-Time Expenses; Yet to See Any Major Change in Culture
Olympus Corporation (7733 JP) reported its full-year FY03/19 results on Friday (10th May). The company reported 0.9% YoY growth in revenue for...
Shifara Samsudeen, FCMA, CGMA
Follow
619 Views
Share
bearish
•
Quantitative Analysis
•
10 Mar 2019 17:31
🇯🇵 Japan: Moving Average Outliers - AnGes, SanBio, Adastria, AIN, Sumco & Benefit One
- MARKET COMPOSITE - SOUTHBOUND - The upside we anticipated two weeks ago turned out to be only ¥6t before the harsh realities of some weak macro...
Campbell Gunn
Follow
407 Views
Share
bearish
•
Olympus Corp
•
11 Feb 2019 09:54
Olympus: 3QFY03/19 Profits Decline on the Back of Litigation Related Costs
Olympus Corporation (7733 JP) reported its 3QFY03/19 results on Friday (08th February) after markets closed. The third quarter revenue dropped 1.7%...
Shifara Samsudeen, FCMA, CGMA
Follow
453 Views
Share
bearish
•
Olympus Corp
•
28 Jan 2019 10:33
Olympus Corporation (7733 JP): Overvalued with Too Many Controversies
Olympus Corporation is currently trading at JPY4,525 per share which we believe is overvalued based on our EV/EBIT valuation. The company generates...
Shifara Samsudeen, FCMA, CGMA
Follow
626 Views
Share
bullish
•
Quantitative Analysis
•
20 Jan 2019 20:02
Japan: Fortnightly Update - Nidec Leads the Way
“I’ve been a manager for almost half a century, but this is the first time I’ve seen such a large single-month drop in orders for us. What we...
Campbell Gunn
Follow
686 Views
Share
First
Previous
34
35
36
37
38
39
40
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x